Literature DB >> 21579786

4-(Methyl-sulfon-yl)piperazin-1-ium chloride.

Hoong-Kun Fun, Chin Sing Yeap, C S Chidan Kumar, H S Yathirajan, B Narayana.   

Abstract

In the title mol-ecular salt, C(5)H(13)N(2)O(2)S(+)·Cl(-), the complete cation is generated by crystallographic mirror symmetry, with both N atoms, the S atom and one C atom lying on the reflecting plane. The chloride ion also lies on the mirror plane. The piperazinium ring adopts a chair conformation and the N-S bond adopts an equatorial orientation. In the crystal structure, the component ions are linked into a three-dimensional framework by inter-molecular N-H⋯Cl and C-H⋯Cl hydrogen bonds.

Entities:  

Year:  2010        PMID: 21579786      PMCID: PMC2979749          DOI: 10.1107/S1600536810001224

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For medicinal background to piperazine derivatives, see: Dinsmore & Beshore (2002 ▶); Berkheij et al. (2005 ▶); Humle & Cherrier (1999 ▶). For related structures, see: Bart et al. (1978 ▶); Girisha et al. (2008 ▶); Homrighausen & Krause Bauer (2002 ▶); Jin et al. (2007 ▶); Kubo et al. (2007 ▶); Parkin et al. (2004 ▶); Shen et al. (2006 ▶), Wang et al. (2006 ▶). For ring conformations, see: Cremer & Pople (1975 ▶). For the stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986 ▶).

Experimental

Crystal data

C5H13N2O2S+·Cl− M = 200.68 Monoclinic, a = 6.0231 (1) Å b = 9.1097 (2) Å c = 7.9852 (2) Å β = 100.700 (1)° V = 430.52 (2) Å3 Z = 2 Mo Kα radiation μ = 0.64 mm−1 T = 100 K 0.36 × 0.32 × 0.05 mm

Data collection

Bruker APEX Duo CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.801, T max = 0.968 10626 measured reflections 2790 independent reflections 2419 reflections with I > 2σ(I) R int = 0.022

Refinement

R[F 2 > 2σ(F 2)] = 0.023 wR(F 2) = 0.072 S = 1.10 2790 reflections 87 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.49 e Å−3 Δρmin = −0.40 e Å−3 Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536810001224/hb5306sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810001224/hb5306Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C5H13N2O2S+·ClF(000) = 212
Mr = 200.68Dx = 1.548 Mg m3
Monoclinic, P21/mMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybCell parameters from 4890 reflections
a = 6.0231 (1) Åθ = 3.4–40.1°
b = 9.1097 (2) ŵ = 0.64 mm1
c = 7.9852 (2) ÅT = 100 K
β = 100.700 (1)°Plate, colourless
V = 430.52 (2) Å30.36 × 0.32 × 0.05 mm
Z = 2
Bruker APEX Duo CCD diffractometer2790 independent reflections
Radiation source: fine-focus sealed tube2419 reflections with I > 2σ(I)
graphiteRint = 0.022
φ and ω scansθmax = 40.1°, θmin = 2.6°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −10→10
Tmin = 0.801, Tmax = 0.968k = −14→16
10626 measured reflectionsl = −14→14
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.023Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.072H atoms treated by a mixture of independent and constrained refinement
S = 1.10w = 1/[σ2(Fo2) + (0.0335P)2 + 0.0922P] where P = (Fo2 + 2Fc2)/3
2790 reflections(Δ/σ)max = 0.001
87 parametersΔρmax = 0.49 e Å3
0 restraintsΔρmin = −0.40 e Å3
Experimental. The crystal was placed in the cold stream of an Oxford Cyrosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986) operating at 100.0 (1) K.
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Cl10.30674 (3)0.25000.93448 (3)0.01195 (5)
S10.69091 (3)0.25000.56598 (2)0.00951 (5)
N10.82854 (12)0.25000.03611 (9)0.01007 (11)
N20.79320 (12)0.25000.38830 (9)0.00974 (11)
O10.75935 (9)0.11396 (6)0.65235 (6)0.01498 (9)
C10.87784 (10)0.11522 (7)0.14202 (8)0.01165 (9)
C20.74465 (10)0.11465 (7)0.28537 (8)0.01168 (9)
C30.39411 (15)0.25000.50705 (12)0.01332 (13)
H1A0.8351 (18)0.0315 (13)0.0719 (14)0.012 (2)*
H1B1.040 (2)0.1186 (13)0.1845 (16)0.016 (3)*
H2A0.583 (2)0.1017 (14)0.2371 (15)0.018 (3)*
H2B0.789 (2)0.0335 (16)0.3554 (17)0.027 (3)*
H3A0.331 (3)0.25000.606 (2)0.019 (4)*
H3B0.350 (2)0.3381 (15)0.4460 (16)0.025 (3)*
H1N10.914 (3)0.2500−0.048 (2)0.019 (4)*
H2N10.677 (3)0.2500−0.017 (2)0.021 (4)*
U11U22U33U12U13U23
Cl10.00886 (7)0.01261 (8)0.01485 (9)0.0000.00346 (6)0.000
S10.01110 (8)0.01033 (8)0.00696 (8)0.0000.00128 (6)0.000
N10.0098 (2)0.0115 (3)0.0095 (3)0.0000.00316 (19)0.000
N20.0126 (2)0.0084 (2)0.0087 (2)0.0000.0032 (2)0.000
O10.01874 (19)0.01499 (19)0.01109 (18)0.00356 (16)0.00245 (15)0.00480 (15)
C10.0148 (2)0.00900 (19)0.0122 (2)0.00097 (17)0.00547 (17)−0.00041 (17)
C20.0162 (2)0.0083 (2)0.0117 (2)−0.00109 (16)0.00571 (17)−0.00060 (16)
C30.0115 (3)0.0166 (3)0.0121 (3)0.0000.0027 (2)0.000
S1—O1i1.4408 (5)N2—C2i1.4806 (7)
S1—O11.4408 (5)C1—C21.5148 (8)
S1—N21.6484 (7)C1—H1A0.953 (11)
S1—C31.7621 (9)C1—H1B0.976 (12)
N1—C11.4892 (7)C2—H2A0.983 (13)
N1—C1i1.4892 (7)C2—H2B0.935 (14)
N1—H1N10.920 (17)C3—H3A0.941 (18)
N1—H2N10.933 (19)C3—H3B0.951 (14)
N2—C21.4806 (7)
O1i—S1—O1118.67 (4)N1—C1—C2110.75 (5)
O1i—S1—N2107.01 (2)N1—C1—H1A108.8 (7)
O1—S1—N2107.01 (2)C2—C1—H1A108.5 (6)
O1i—S1—C3108.28 (3)N1—C1—H1B104.6 (7)
O1—S1—C3108.29 (3)C2—C1—H1B112.1 (7)
N2—S1—C3107.03 (4)H1A—C1—H1B112.0 (9)
C1—N1—C1i111.07 (7)N2—C2—C1109.81 (5)
C1—N1—H1N1109.7 (5)N2—C2—H2A113.4 (7)
C1i—N1—H1N1109.7 (5)C1—C2—H2A109.1 (7)
C1—N1—H2N1109.5 (5)N2—C2—H2B108.7 (8)
C1i—N1—H2N1109.5 (5)C1—C2—H2B108.7 (7)
H1N1—N1—H2N1107.3 (15)H2A—C2—H2B107.1 (10)
C2—N2—C2i112.77 (7)S1—C3—H3A108.9 (11)
C2—N2—S1114.27 (4)S1—C3—H3B108.1 (8)
C2i—N2—S1114.27 (4)H3A—C3—H3B108.3 (9)
O1i—S1—N2—C2178.10 (5)C3—S1—N2—C2i66.00 (5)
O1—S1—N2—C249.91 (6)C1i—N1—C1—C256.95 (8)
C3—S1—N2—C2−65.99 (5)C2i—N2—C2—C156.73 (8)
O1i—S1—N2—C2i−49.91 (6)S1—N2—C2—C1−170.56 (4)
O1—S1—N2—C2i−178.10 (5)N1—C1—C2—N2−55.89 (7)
D—H···AD—HH···AD···AD—H···A
N1—H1N1···Cl1ii0.92 (2)2.40 (2)3.1341 (8)137 (1)
N1—H2N1···Cl1iii0.93 (2)2.19 (2)3.0966 (8)164 (1)
C1—H1A···Cl1iv0.953 (12)2.700 (12)3.5251 (6)145.2 (9)
C3—H3A···Cl10.94 (2)2.65 (2)3.5487 (10)160 (2)
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N1—H1N1⋯Cl1i0.92 (2)2.40 (2)3.1341 (8)137 (1)
N1—H2N1⋯Cl1ii0.93 (2)2.19 (2)3.0966 (8)164 (1)
C1—H1A⋯Cl1iii0.953 (12)2.700 (12)3.5251 (6)145.2 (9)
C3—H3A⋯Cl10.94 (2)2.65 (2)3.5487 (10)160 (2)

Symmetry codes: (i) ; (ii) ; (iii) .

  4 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  1-Benzhydryl-4-(4-chloro-phenyl-sulfonyl)piperazine.

Authors:  H R Girisha; S Naveen; K Vinaya; M A Sridhar; J Shashidhara Prasad; K S Rangappa
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-01-04

3.  Structures of piperazine, piperidine and morpholine.

Authors:  Andrew Parkin; Iain D H Oswald; Simon Parsons
Journal:  Acta Crystallogr B       Date:  2004-03-18

4.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  4 in total
  2 in total

1.  4-{[5-(4-Chloro-phen-yl)-1-(4-fluoro-phen-yl)-1H-pyrazol-3-yl]carbon-yl}-N-(4-cyano-phen-yl)piperazine-1-carboxamide.

Authors:  Wan-Sin Loh; Hoong-Kun Fun; R Venkat Ragavan; V Vijayakumar; M Venkatesh
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-09-15

2.  4-(2-Meth-oxy-phen-yl)piperazin-1-ium 6-chloro-5-isopropyl-2,4-dioxopyrimidin-1-ide.

Authors:  Fatmah A M Al-Omary; Hazem A Ghabbour; Ali A El-Emam; C S Chidan Kumar; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-02-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.